MORPHOLINE DERIVATIVES WITH A SUBSTITUTED ACETAMIDE GROUP IN THE 2-POSITION FOR USE AS CCR-3 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES

Details for Australian Patent Application No. 2003226762 (hide)

Owner GLAXO GROUP LIMITED

Inventors LEWELL, Xiao, Qing; MILLS, Gail; ROBERTSON, Graeme, Michael; SWANSON, Stephen; WALKER, Andrew, John; WILKINSON, Mark; ANCLIFF, Rachael, Ann; COOK, Caroline, Mary; ELDRED, Colin, David; GORE, Paul, Martin; HARRISON, Lee, Andrew; HAYES, Martin, Alistair; HODGSON, Simon, Teanby; JUDD, Duncan, Bruce; KEELING, Suzanne, Elaine

Pub. Number AU-A-2003226762

PCT Number PCT/EP03/03348

PCT Pub. Number WO2003/082294

Priority 0207443.3 28.03.02 GB

Filing date 27 March 2003

Wipo publication date 13 October 2003

International Classifications

A61K 031/5377

A61P 011/06 Drugs for disorders of the respiratory system

C07D 265/30 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 209/48 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 0207443.3 28.03.02 GB

20 November 2003 Application Open to Public Inspection

  Published as AU-A-2003226762

23 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003226763-MORPHOLINE DERIVATIVES SUBSTITUTED AT THE 2-POSITION BY A HETEROCYCLYLALKYLUREA GROUP FOR USE AS CCR-3 ANTAGONISTS IN THE TREATMENT OF INFLAMMATORY CONDITIONS

2003226761-Benzenesulphonate salt of a morpholine urea derivative for use as a CCR-3 antagonist the treatment of inflammatory conditions